- Coordinator
- Leibniz-Institut Fur Polymerforschung Dresden eV, Germany
- Runs
- 1 January 2024 to 30 June 2025
- Status
- Running
- EU funding
- €150k
- Total cost
- —
- Partners
- 1 organisations in 1 countries
- Type
- European Research Council grant
- Grant agreement
- 101138496
What the project is doing
In the project's own words, from its summary on CORDIS.
This research addresses a clinical problem with an innovative approach. Pancreatic cancer is one of the deadliest cancers and only 10% of patients survive 5 years after diagnosis. To find better therapies, we need patient-specific models that mimic the biology of tumour tissues and target interactions between different cell types. We will develop a controllable platform for modelling the human disease in the laboratory.
We will use our new platform to discover better ways of treating the disease.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Leibniz-Institut Fur Polymerforschung Dresden eV | Dresden | Germany | Coordinator |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI